Academic Journal

Intra-Individual Comparison of 18F-PSMA-1007 and 18F-FDG PET/CT in the Evaluation of Patients With Prostate Cancer

التفاصيل البيبلوغرافية
العنوان: Intra-Individual Comparison of 18F-PSMA-1007 and 18F-FDG PET/CT in the Evaluation of Patients With Prostate Cancer
المؤلفون: Zhou, Xing, Li, YingChun, Jiang, Xiao, Wang, XiaoXiong, Chen, ShiRong, Shen, TaiPeng, You, JinHui, Lu, Hao, Liao, Hong, Li, Zeng, Cheng, ZhuZhong
المساهمون: Sichuan Province Science and Technology Support Program
المصدر: Frontiers in Oncology ; volume 10 ; ISSN 2234-943X
بيانات النشر: Frontiers Media SA
سنة النشر: 2021
المجموعة: Frontiers (Publisher - via CrossRef)
الوصف: Purpose 18F labelled PSMA-1007 presents promising results in detecting prostate cancer (PC), while some pitfalls exists meanwhile. An intra-individual comparison of 18F-FDG and 18F-PSMA-1007 in patients with prostate cancer were aimed to be performed in the present study. Then, the pitfalls of 18F-PSMA-1007 PET/CT in imaging of patients with prostate cancer were analyzed. Methods and Material 21 prostate cancer patients underwent 18F-PSMA-1007 PET/CT as well as 18F-FDG PET/CT before treatment. All positive lesions were noticed in both 18F-PSMA-1007 PET/CT and 18F-FDG PET/CT, then differentiated PC metastasis from benign lesions. the SUVmax, SUVmean and TBR of lesions, up to 10 metastases and 10 benign lesions per patients were recorded (5 for bone, 5 for soft tissue metastasis ). The distribution of positive lesions were analyzed for two imaging. Detection rates, SUVmax, SUVmean and TBR in 18F-PSMA-1007 PET/CT and 18F-FDG PET/CT were compared, respectively. The optimal cut-off values of SUVmax, SUVmean for metastases vs. benign lesions was found through areas under ROC in 18F-PSMA-1007. Results The detection rates of primary lesions in 18F-PSMA-1007 PET/CT was higher than that of 18F-FDG PET/CT(100% (21/21) vs. 67%(14/21)). For extra- prostatic lesions, 18F-PSMA-1007 PET/CT revealed 124 positive lesions, 49(49/124, 40%) attributed to a benign origin; 18F-FDG PET/CT revealed 68 positive lesions, 14(14/68, 21%) attributed to a benign origin. The SUVmax, SUVmean, TBR of primary tumor in 18F-PSMA-1007 PET/CT was higher than that in 18F-FDG PET/CT (15.20 vs. 4.20 for SUVmax; 8.70 vs. 2.80 for SUVmean; 24.92 vs. 4.82 for TBR, respectively); The SUVmax, SUVmean, TBR of metastases in 18F-PSMA-1007 PET/CT was higher than that in 18F-FDG PET/CT (10.72 vs. 4.42 for SUVmax; 6.67 vs. 2.59 for SUVmean; The TBR of metastases was 13.3 vs. 7.91). For 18F-FDG PET/CT, the SUVmax, SUVmean in metastases was higher than that in benign lesions (4.42 vs. 3.04 for SUVmax, 2.59 vs. 1.75 for SUVmean, respectively). Similarly, for ...
نوع الوثيقة: article in journal/newspaper
اللغة: unknown
DOI: 10.3389/fonc.2020.585213
DOI: 10.3389/fonc.2020.585213/full
الاتاحة: http://dx.doi.org/10.3389/fonc.2020.585213
https://www.frontiersin.org/articles/10.3389/fonc.2020.585213/full
Rights: https://creativecommons.org/licenses/by/4.0/
رقم الانضمام: edsbas.4B9A154A
قاعدة البيانات: BASE
الوصف
DOI:10.3389/fonc.2020.585213